Navigation Links
Afinitor (Breast Cancer) - Analysis and Forecasts to 2020
Date:10/20/2011

r, Selected Countries, 1975-2005 12

Figure 9: Mortality per 100,000, Breast Cancer, Selected Countries, 1975-2005 12

Figure 10: Breast Cancer, Mortality, Worldwide, 2008-2030 13

Figure 11: All Cancers, Mortality, Worldwide, 2008-2030 13

Figure 12: Broad Classification of Breast Cancer, By Type 15

Figure 13: Classification of Non-Invasive Breast Cancer, By CIS 15

Figure 14: Classification of Invasive Breast Cancer, By Stages 16

Figure 15: Classification of Invasive Breast Cancer, By Treatment 16

Figure 16: Classification of Metastatic or Advanced Breast Cancer 16

Figure 17: Classification of Early Stage Breast Cancer (Excluding Stage 0) 17

Figure 18: Classification of Locally Advanced Breast Cancer 17

Figure 19: Metastatic Breast Cancer Classification 17

Figure 20: Current Molecular Biomarkers used in the Clinical Management of Breast Cancer 18

Figure 21: Breast Cancer Intrinsic Sub Types used for Deciding Treatment Options for MBC 19

Figure 22: Breast Cancer Types in Decreasing Order of their Aggressiveness 19

Figure 23: Treatment Options, DCIS Breast Cancer 20

Figure 24: Treatment Options, LCIS Breast Cancer 21

Figure 25: Treatment Options, Stages I, II and IIIA 21

Figure 26: Treatment Options, Stages I, II and IIIA (HR Positive and Premenopausal Breast Cancer) 22

Figure 27: Treatment Options, Stages I, II and IIIA (HR Negative, Pre and Postmenopausal Breast Cancer) 22

Figure 28: Treatment Options, Stages I, II and IIIA (HR Positive Postmenopausal Breast Cancer) 23

Figure 29: Adjuvant Therapy for HR Positive, HER2 Negative Metastatic Breast Cancer 24

Figure 30: Hormonal Therapy in Adjuvant Setting in HR Positive, HER2 Negative MBC 24

Figure 31: Adjuvant and First Line Therapy for HR Negative, HER2 Negative Metastatic Breast Cancer 26

Figure 32: Treatment Options, HR Negative and HER2 Positive Metasta
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Novartis Drug Afinitor® Effective in Patients With Non-Cancerous Kidney Tumors Associated With TSC in Phase III Trial
2. Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint of Reducing SEGA Tumor Size in Patients With Tuberous Sclerosis
3. FDA Approves Novartis Drug Afinitor to Treat Pancreatic Neuroendocrine Tumors
4. Novartis Gains FDA Approval for Afinitor® as First New Treatment in Nearly Three Decades for Patients with Advanced Pancreatic NET
5. Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin
6. Study Shows Novartis Drug Afinitor® Plus Hormonal Therapy Delays Disease Progression in Advanced Metastatic Breast Cancer Patients
7. Study in NEJM Shows Novartis Drug Afinitor® Reduces Size of SEGAs, Benign Brain Tumors Associated with Tuberous Sclerosis
8. FDA Approves New Indication for Afinitor
9. VIDEO from thenewsmarket.com and Novartis: Novartis drug Afinitor® Approved by FDA as First Medication for Children and Adults With a Benign Brain Tumor Associated With Tuberous Sclerosis
10. Pivotal Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint in Study of Patients With Advanced Pancreatic Neuroendocrine Tumors
11. Afinitor(R) Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma, Leading to Phase III Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... China , Jan. 23, 2015 Tianyin Pharmaceutical ... company that specializes in the development and sale of ... generics and active pharmaceutical ingredients (API) today announced the ... (JCM) API operation. 1. Following the September ...
(Date:1/22/2015)... (NYSE: RMD ) today announced results for its ... $423.0 million, a 10 percent increase compared to the quarter ... constant currency basis). Net income was $91.2 million, an increase ... 2013. Diluted earnings per share for the quarter were $0.64, ...
(Date:1/22/2015)... Institute for Clinical Research, Inc., a clinical research organization ... new textbook,  Translational Research Methods for Diabetes, Obesity and ... scientific publisher. The textbook is the first ... early phase clinical studies of new drugs for diabetes, ...
Breaking Medicine Technology:TPI's JCM Updates on Import Registration for International Clients 2TPI's JCM Updates on Import Registration for International Clients 3TPI's JCM Updates on Import Registration for International Clients 4ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 2ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 3ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 4ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 5ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 6ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 7ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 8ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 9ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 10ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 11New Textbook "Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development" Provides Critical Review Of Current And Emerging Clinical Investigation Methods 2New Textbook "Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development" Provides Critical Review Of Current And Emerging Clinical Investigation Methods 3
(Date:1/23/2015)... Hastings and Hastings, a law firm in ... number of legal representation client review requests for slip and ... steady rise in the number of slip and fall related ... the Valley. With that said, a large number of injury ... experienced law firm. Hastings and Hastings is a personal injury ...
(Date:1/22/2015)... (PRWEB) January 23, 2015 LunaDress, with its ... the fashion industry. Now, the business is showing its latest ... women’s dresses. , According to the company’s CEO, all the ... now offered with big discounts, up to 80% off. All ...
(Date:1/22/2015)... Padre Murphy's and Owner Tom Boyle in ... Player Health Alliance (PPHA). The PPHA's passion for others' ... including NFL greats, treated for obstructive sleep apnea (OSA) has ... the cause in the valley. The most recent plans for ...
(Date:1/22/2015)... 22, 2015 Blue Cross and Blue Shield ... exemplify what it means to “Live Fearless.” , ... to share their stories about how they or someone they ... others by living in the moment. By telling these types ...
(Date:1/22/2015)... Dallas, TX (PRWEB) January 22, 2015 ... the issue of experience and person-centeredness in the long-term ... moving towards action across the continuum. The paper, “The ... the Continuum,” engages perspectives and practices of the patient, ...
Breaking Medicine News(10 mins):Health News:Hastings and Hastings Reports a Record Number of Client Review Requests for Slip and Fall Accidents in 2014 2Health News:LunaDress Shows The Latest Styles Of Wedding Dresses In 2015 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 3Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3
... say that they have found a new way to boost ... newborns// are at risk for developing various infections since their ... a study published in the online edition of the journal ... in Children's Division of Infectious Diseases show that the newborn ...
... to the recent survey it was found that pet owners are ... human obesity pet obesity have propped up. //According to a recent ... suffering as those that are starved. Four out of five vets ... day. , The survey consulted about 143 practioner about ...
... have said that The World Bank did not aid the ... promised sum of $500 million// to combat malaria. In addition, ... adequate infrastructure and resources in hand to see an initiative ... that medicines used for the program were ineffective in meeting ...
... their wits end since the 13th of April when their ... a storm, after reports got// wind that the solution was ... affect the cornea. There were nearly 109 cases reported, and ... market. Since then, the numbers of cases reported have risen ...
... Kenya's health authorities have declared that they will be launching ... infant and child deaths. This emergency vaccination// exercise will ... nearly thousands of children who are between the ages of ... of measles have been reported from all over the country ...
... bed in ward 3 of Middlemore Hospital, South Auckland, unable ... a constant// feeling of thirst, a craving for sweet drinks, ... had been fine. She was surprised to be rushed to ... tests revealed that her blood sugar levels had reached an ...
Cached Medicine News:Health News:Enhancing Infants Immune System 2Health News:Enhancing Infants Immune System 3Health News:Diabetes, The Silent Killer of New Zealand 2Health News:Diabetes, The Silent Killer of New Zealand 3
15" overall length, 9" handle....
...
...
Medtronic neurosurgery external drainage and monitoring (EDM) products meet a variety of needs for CSF drainage and monitoring....
Medicine Products: